Add to Del.icio.us Add to furl Add to digg Add to Connotea EMail Page Printer Friendly Book Mark

Executive Summaries

2004-present
The reports that feature these Executive Summaries are published and available for immediate shipment.


Blood-Brain Barrier: Bridging Options for Drug Discovery & Development
May 2008

Cardiotoxicity: Issues, Technologies, and Solutions for the Future
May 2008

Inflammatory Directions: Strategies for Six Diseases with Unmet Needs
April 2008

MicroRNAs: Commercial Products on the Horizon
March 2008

Epigenetics: Technologies, Applications, and the Commercial Landscape
February 2008

Multiplex Assays in Translational Medicine: Technologies, Applications, and Future Directions
February 2008

Molecular Imaging in Drug R&D and Medical Practice
January 2008

Ophthalmological Therapeutics: Pipelines, Delivery Technologies, and Markets
January 2008

Kinase Therapeutic Pipelines: An Assessment of Targets and Agents in Development
December 2007

Molecular Diagnostics: A Rapidly Shifting Commercial and Technology Landscape
November 2007

Monoclonal Antibodies: Pipeline Analysis and Market Assessment
October 2007

Backup Compound Strategies: Best Practices for Reducing Phase II Risk
September 2007

Adaptive Clinical Trials: Innovation in Trial Design, Management, and Analysis
September 2007

Next-Generation Sequencing: Scientific and Commercial Implications of the $1000 Genome
August 2007
Clinical Forecasting: A Novel Bayesian Tool for Predicting Phase III Outcomes
July 2007

Disease-Related Biomarkers: Their Potential in Patient Screening, Prognosis, and Stratification
June 2007

Diabetes and Its Complications: Strategies to Advance Therapy and Optimize R&D
May 2007

High-Content Analysis: Technologies, Applications, Market Analysis
May 2007

Combination Drug/Diagnostic Products: Pathways to R&D and Commercial Success
May 2007

Metabolic and Inflammatory Disease R&D : An Assessment of 5 Highly Promising Therapeutic Classes
April 2007

Delivery Technologies for Therapeutic Proteins: Assessment and Outlook
March 2007

Cytokine Therapeutics: A Vibrant Pipeline and Active Approved Market
February 2007

Biomarker SOPs: Getting Optimum Value from Your Biomarker Program
January 2007

Outlook for Predictive Safety Technologies
November 2006